Tag Archives: Institute of Cancer Research London

New Genetic Insights Boost Efficacy of Combination Therapy in Advanced Prostate Cancer

(IN BRIEF) Researchers at the Institute of Cancer Research in London have identified genetic markers that predict a significant survival benefit from combining ipatasertib with abiraterone in treating metastatic castration-resistant prostate cancer. In the phase III IPATential150 trial, patients whose … Read the full press release